Chemical Replacement of P1′ Arginine Residue at the First Reactive Site of Peanut Protease Inhibitor B-III

The contribution of the P1′ residue at the first reactive site of peanut protease inhibitor B–III to the inhibition was analyzed by replacement of the P1′ Arg(11) with other amino acids (Arg, Ser, Ala, Leu, Phe, Asp) after selective modification of the second reactive site. The Arg derivative had th...

Full description

Saved in:
Bibliographic Details
Published inJournal of biochemistry (Tokyo) Vol. 101; no. 3; pp. 723 - 728
Main Authors KUROKAWA, Tomofuni, HARA, Saburo, NORIOKA, Shigemi, TESHIMA, Tadashi, IKENAKA, Tokuji
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.03.1987
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The contribution of the P1′ residue at the first reactive site of peanut protease inhibitor B–III to the inhibition was analyzed by replacement of the P1′ Arg(11) with other amino acids (Arg, Ser, Ala, Leu, Phe, Asp) after selective modification of the second reactive site. The Arg derivative had the same trypsin inhibitory activity as the native inhibitor (K1 = 2 × 10−9 M). The Ser derivative inhibited more weakly (K1 = 2 × 10−7M). The Ala and Leu derivatives inhibited trypsin very weakly (K1 = 2 × 10−7 M and 4 × 10−7 M, respectively), and the Phe and Asp derivatives not at all. These results suggest that the P1′ arginine residue is best for inhibitory activity at the first reactive site of B.-III, although it has been suggested that a P1′ serine residue at the reactive site is best for inhibitory activity of Bowman-Birk type inhibitors.
Bibliography:ark:/67375/HXZ-H97WB0TL-9
ArticleID:101.3.723
istex:99FF530A62C0ACFFF5E5AEB09B75F5D7A89C6BC4
1This work was supported in part by Special Coordination Funds from the Science and Technology Agency of the Japanese Government.
2To whom correspondence should be addressed
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-924X
1756-2651
DOI:10.1093/jb/101.3.723